SILVER SPRING, Md., March 15, 2023 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that it will release its fourth quarter and full year 2022 financial results after market close on Wednesday, March 22, 2023. Members of the Company’s management team will host a conference call and webcast with accompanying slides starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13736040
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Aziyo website at https://investors.aziyo.com/.
About Aziyo Biologics
Aziyo develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Aziyo’s mission is to humanize medical devices to improve patient outcomes. For more information, visit www.Aziyo.com.
Aziyo Biologics, Inc.
- Rocque Lipford Jr. Joins Guggenheim Securities to Expand Industrials Investment Banking Practice - March 21, 2023
- Ericsson, Saab and Purdue University announce ‘lab to life’ innovative 5G network to make Purdue Airport accessible as a real-life research site for aviation industry - March 21, 2023
- Investors who lost over $50,000 with shares of Terran Orbital Corporation (NYSE: LLAP) should contact the Shareholders Foundation in connection with the Lawsuit - March 21, 2023